AI calls the bluff: differentiating benign lesions from triple-negative breast cancer cases
{{output}}
Triple-negative breast cancer (TNBC) is the most aggressive molecular subtype of breast cancer (BC). TNBC lacks targeted treatment options, which results in poor clinical outcomes. TNBC lesions usually present benign characteristics on mammograms, complicating... ...
